Document is current
Any future updates will be listed below
-
Authors
Boyaci, Ceren
Sun, Wenwen
Hartman, Johan
Ács, Balázs
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 5 February 2025
Accepted: 23 August 2025
First Online: 2 September 2025
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki. The study was approved by the Swedish Ethical Review Authority.
: Not applicable.
: CB has no potential conflicts of interest to disclose. WS has no potential conflicts of interest to disclose. JH has obtained speaker’s honoraria or advisory board remunerations from Roche, Novartis, Pfizer, EliLilly, MSD, Gilead, Sakura and has received institutional research support from Roche, AstraZeneca, MSD and Novartis. JH is a co-founder and shareholder of Stratipath AB. BA reports honoraria from Pfizer.
